Page last updated: 2024-08-17

folic acid and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

folic acid has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ares-Pensado, B; Castro, A; Fernandez-Pajarin, G; Rivero-de-Aguilar, A; Sesar, A1

Trials

1 trial(s) available for folic acid and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

ArticleYear
Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
    The Lancet. Neurology, 2009, Volume: 8, Issue:2

    Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Disability Evaluation; Double-Blind Method; Female; Folic Acid; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome; Vitamins

2009

Other Studies

1 other study(ies) available for folic acid and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

ArticleYear
[Chronic inflammatory demyelinating polyradiculoneuropathy associated with treatment using intraduodenal infusion of levodopa-carbidopa].
    Revista de neurologia, 2019, 10-01, Volume: 69, Issue:7

    Topics: Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Dopamine; Drug Combinations; Duodenum; Female; Folic Acid; Humans; Infusions, Parenteral; Levodopa; Metabolic Networks and Pathways; Methionine; Middle Aged; Parkinson Disease; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

2019